Accessibility Menu
Shanrong Biotechnology logo

Shanrong Biotechnology(OTC) SRBT

Market Cap$102.50KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2008)-100%
5 Year-100%
1 Year-100%
1 Month+0%
$0.00
+0.00%
+0.00Today
Shanrong Biotechnology last closing stock price
MetricPriceDate
Last closeUSD 0.002026-06-15
Shanrong Biotechnology stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-05-14
1 month+0%USD 0.002026-05-14
3 month+0%USD 0.002026-03-12
Year to date-99.9%USD 0.112025-12-31
1 year-99.98%USD 0.462025-06-13
3 year-99.96%USD 0.262023-05-31
5 year-99.93%USD 0.152021-06-07
Since inception-100%USD 150.002008-12-01

Shanrong Biotechnology Financials at a Glance

Market Cap

$102.50KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$0.00

Net Income (TTM)

-$23.52K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-3.88 (Low)

Price

$0.00

Volume

10

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.34

Estimated Earnings Date

N/A

SRBT News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Shanrong Biotechnology

Shanrong Biotechnology Corp. is a specialized provider of executive consulting and project management services, focusing on the modernization of armored vehicles. The company integrates advanced digital communications into military and law enforcement systems while offering critical spare parts and specialized equipment.

Products and Services
  • Executive consulting and project management services
  • Modernization of armored vehicles with advanced communications
  • On-site maintenance and comprehensive training programs
Growth Outlook
  • Expansion into defense and homeland security sectors is underway
  • Strategic analysis capabilities enhance business development opportunities
  • Potential for increased demand in information technology and telecommunications
Financial Highlights
  • Recent quarterly net income of -$1,391 indicates ongoing operational challenges
  • Trailing twelve months show a consistent negative net income trend
  • Cash and cash equivalents decreased to $1,597, reflecting liquidity concerns
Shanrong Biotechnology Corp. operates in a niche market, providing essential services and products to military and law enforcement sectors. The company's focus on modernization and advanced technology integration positions it well for future growth, particularly as defense and security needs evolve. However, recent financial data indicates challenges, including negative net income and decreasing cash reserves, which may impact operational flexibility. Investors may find the company's strategic direction and market positioning noteworthy, despite current financial hurdles.
AI Generated • Jul 26, 2026

Industry

Aerospace and Defense

Sector

Industrials

CEO

Frank Ikechukwu Igwealor, MBA, CPA

Website

www.defensesolutionsholding.com

Headquarters

Torrance, CA 90501, US

SRBT Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

6.38%

Return on Capital

N/A

Return on Assets

-1240.95%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$102.50KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.03B

Volume

10

Avg. Volume

0.635

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$23.52K

EBITDA

-$23.51K

Operating Cash Flow

-$109.41K

Capital Expenditure

$0.00

Free Cash Flow

-$109.41K

Cash & ST Invst.

$1.60K

Total Debt

$0.00

Shanrong Biotechnology Performance Analysis

Shanrong Biotechnology annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 0N/A
20222022-12-31USD 0N/A
20232023-12-31USD 0N/A
20242024-12-31USD 0N/A
Shanrong Biotechnology sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12024-03-31N/A
Q22024-06-30N/A
Q32024-09-30N/A
Q42024-12-31N/A
Shanrong Biotechnology annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD 0.00N/A
20222022-12-31USD -0.16N/A
20232023-12-31USD -0.03-79.3%
20242024-12-31USD 0.00N/A
Shanrong Biotechnology sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12024-03-31N/A
Q22024-06-3050.0%
Q32024-09-30-15.5%
Q42024-12-3177.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2024YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$102.50KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$34.17K

N/A

Employees

3

N/A

Net Income

-$1.39K

+84.1%

EBITDA

-$1.39K

+84.1%

Quarterly Fundamentals

Name
Q4 2024YOY CHG

Total Cash

$1.60K

-11.5%

Total Debt

$0.00

N/A

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-12.41%

N/A

Return on Invested Capital

93.02%

N/A

Free Cash Flow

-$8.75K

+97.4%

Operating Cash Flow

-$8.75K

+97.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CAMGCAM Group, Inc.
$0.00+0.00%
ILSTInternational Star, Inc.
$0.00+0.00%
PUGEPuget Technologies, Inc.
$0.00+0.00%
NSPTNewron Sport
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PLTRPalantir Technologies
$162.66+0.29%
SPCXSpace Exploration Technologies
$125.33+0.09%
NVDANvidia
$211.94+0.03%
INTCIntel
$100.86+0.11%

Questions About SRBT

What is the current price of Shanrong Biotechnology?

Shanrong Biotechnology is trading at $0.00 per share.

What is the 52-week range for Shanrong Biotechnology?

Over the past 52 weeks, Shanrong Biotechnology has traded between $0.00 and $0.34.

How much debt does Shanrong Biotechnology have?

As of the most recent reporting period, Shanrong Biotechnology reported total debt of $0.00.

How much cash does Shanrong Biotechnology have on hand?

Shanrong Biotechnology reported $1.43K in cash and cash equivalents in its most recent financial results.

What is Shanrong Biotechnology’s dividend yield?

Shanrong Biotechnology does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services